Qixin Biotechnology
PrivateLast Round
Series B
Sep 22, 2023
Total Funding Raised
$116.3M
Momentum Score
50 /100
Company Overview
Qihan Biotech is a biotechnology company specializing in genetic editing for xenotransplantation, utilizing advanced gene editing technology to develop transplantable organs that address the global organ donor shortage and provide life-saving solutions for patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qixin Biotechnology Comps
Public and private peers based on sector, stage, and business model.
Qixin Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 22, 2023 | ||||
| Series A Extension | Mar 29, 2021 | ||||
| Series A Extension | Sep 23, 2019 | ||||
| Series A | Jul 23, 2018 |
Qixin Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series B, Series A Extension |
| Legend Star | Series A Extension |
| 招银国际金融有限公司 | Series A Extension |
| BC Capital | Series A Extension |
| Northern Light Venture Capital | Series A, Series A Extension, Series B |
| Biomatics Capital Partners | Series A |
| ARCH Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 119% MoM, reaching 4.9K.
- Nov 3, 2025
New data on CAR-T cell therapy programs to be presented at conference.
Qixin Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Qixin Biotechnology's valuation, stock price, and market status.
